BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26170027)

  • 1. Topical application of RTA 408 lotion activates Nrf2 in human skin and is well-tolerated by healthy human volunteers.
    Reisman SA; Goldsberry AR; Lee CY; O'Grady ML; Proksch JW; Ward KW; Meyer CJ
    BMC Dermatol; 2015 Jul; 15():10. PubMed ID: 26170027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical application of the synthetic triterpenoid RTA 408 activates Nrf2 and induces cytoprotective genes in rat skin.
    Reisman SA; Lee CY; Meyer CJ; Proksch JW; Ward KW
    Arch Dermatol Res; 2014 Jul; 306(5):447-54. PubMed ID: 24362512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical application of the synthetic triterpenoid RTA 408 protects mice from radiation-induced dermatitis.
    Reisman SA; Lee CY; Meyer CJ; Proksch JW; Sonis ST; Ward KW
    Radiat Res; 2014 May; 181(5):512-20. PubMed ID: 24720753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Nrf2 activation therapy with RTA 408 enhances regenerative capacity of diabetic wounds.
    Rabbani PS; Ellison T; Waqas B; Sultan D; Abdou S; David JA; Cohen JM; Gomez-Viso A; Lam G; Kim C; Thomson J; Ceradini DJ
    Diabetes Res Clin Pract; 2018 May; 139():11-23. PubMed ID: 29476889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel triterpenoid RTA 408 protects human retinal pigment epithelial cells against H2O2-induced cell injury via NF-E2-related factor 2 (Nrf2) activation.
    Liu X; Ward K; Xavier C; Jann J; Clark AF; Pang IH; Wu H
    Redox Biol; 2016 Aug; 8():98-109. PubMed ID: 26773873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel Nrf2 activator from microbial transformation inhibits radiation-induced dermatitis in mice.
    Nakagami Y; Masuda K
    J Radiat Res; 2016 Sep; 57(5):567-571. PubMed ID: 27242339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity.
    Probst BL; Trevino I; McCauley L; Bumeister R; Dulubova I; Wigley WC; Ferguson DA
    PLoS One; 2015; 10(4):e0122942. PubMed ID: 25897966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulforaphane and phenylethyl isothiocyanate protect human skin against UVR-induced oxidative stress and apoptosis: role of Nrf2-dependent gene expression and antioxidant enzymes.
    Kleszczyński K; Ernst IM; Wagner AE; Kruse N; Zillikens D; Rimbach G; Fischer TW
    Pharmacol Res; 2013 Dec; 78():28-40. PubMed ID: 24121007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific dermatological benefits associated with quantities of lotion transferred to the skin.
    Farage MA; Esquerra J; Cheng R; Carpenter S; Bunasky K; Gutshall D; Lawrence A; Messerschmidt A
    J Cosmet Dermatol; 2018 Oct; 17(5):900-910. PubMed ID: 29094461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrf2- and Bach1 May Play a Role in the Modulation of Ultraviolet A-Induced Oxidative Stress by Acetyl-11-Keto-β-Boswellic Acid in Skin Keratinocytes.
    Yang S; Zhou B; Xu W; Xue F; Nisar MF; Bian C; Huang X; Yang L; Zhang Y; Bartsch JW; Zhong JL
    Skin Pharmacol Physiol; 2017; 30(1):13-23. PubMed ID: 28142143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase 2, multicenter, double-blind, randomized, vehicle-controlled clinical study to compare the safety and efficacy of a halobetasol propionate 0.01% lotion and halobetasol propionate 0.05% cream in the treatment of plaque psoriasis.
    Kerdel FA; Draelos ZD; Tyring SK; Lin T; Pillai R
    J Dermatolog Treat; 2019 Jun; 30(4):333-339. PubMed ID: 30207807
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes.
    Yates MS; Tauchi M; Katsuoka F; Flanders KC; Liby KT; Honda T; Gribble GW; Johnson DA; Johnson JA; Burton NC; Guilarte TR; Yamamoto M; Sporn MB; Kensler TW
    Mol Cancer Ther; 2007 Jan; 6(1):154-62. PubMed ID: 17237276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant tert-butylhydroquinone ameliorates arsenic-induced intracellular damages and apoptosis through induction of Nrf2-dependent antioxidant responses as well as stabilization of anti-apoptotic factor Bcl-2 in human keratinocytes.
    Duan X; Li J; Li W; Xing X; Zhang Y; Li W; Zhao L; Sun G; Gao XH; Li B
    Free Radic Biol Med; 2016 May; 94():74-87. PubMed ID: 26878773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting NRF2 for Improved Skin Barrier Function and Photoprotection: Focus on the Achiote-Derived Apocarotenoid Bixin.
    Rojo de la Vega M; Krajisnik A; Zhang DD; Wondrak GT
    Nutrients; 2017 Dec; 9(12):. PubMed ID: 29258247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tazarotene 0.045% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in Adult Males.
    Cook-Bolden FE; Gold MH; Guenin E
    J Drugs Dermatol; 2020 Jan; 19(1):78-85. PubMed ID: 32023013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitroxide delivery system for Nrf2 activation and skin protection.
    Ben Yehuda Greenwald M; Frušić-Zlotkin M; Soroka Y; Sasson SB; Bianco-Peled H; Bitton R; Kohen R
    Eur J Pharm Biopharm; 2015 Aug; 94():123-34. PubMed ID: 25986586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of NAD(P)H:quinone oxidoreductase 1 expression by cysteine via Nrf2 activation in human intestinal epithelial LS180 cells.
    Satsu H; Chidachi E; Hiura Y; Ogiwara H; Gondo Y; Shimizu M
    Amino Acids; 2012 Oct; 43(4):1547-555. PubMed ID: 22302369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NFE2L2 activator RS9 protects against corneal epithelial cell damage in dry eye models.
    Matsuda Y; Machida M; Nakagami Y; Nakajima T; Azuma M
    PLoS One; 2020; 15(4):e0229421. PubMed ID: 32320433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease-activated receptor-2 activates NQO-1 via Nrf2 stabilization in keratinocytes.
    Kim JY; Kim DY; Son H; Kim YJ; Oh SH
    J Dermatol Sci; 2014 Apr; 74(1):48-55. PubMed ID: 24326025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies.
    Gopal S; Mikulskis A; Gold R; Fox RJ; Dawson KT; Amaravadi L
    Mult Scler; 2017 Dec; 23(14):1875-1883. PubMed ID: 28156185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.